These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 16210554

  • 1. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
    Berrouschot J, Röther J, Glahn J, Kucinski T, Fiehler J, Thomalla G.
    Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A, Köhrmann M, Sobesky J, Cheng B, Rosenkranz M, Röther J, Schellinger PD, Ringleb P, Gerloff C, Fiehler J, Thomalla G.
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [Abstract] [Full Text] [Related]

  • 3. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.
    Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, Fiehler J, Zaro Weber O, Kucinski T, Juettler E, Ringleb PA, Zeumer H, Weiller C, Hacke W, Schellinger PD, Röther J, MRI in Acute Stroke Study Group of the German Competence Network Stroke.
    Stroke; 2006 Mar; 37(3):852-8. PubMed ID: 16439696
    [Abstract] [Full Text] [Related]

  • 4. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, Schellinger PD.
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [Abstract] [Full Text] [Related]

  • 5. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [Abstract] [Full Text] [Related]

  • 6. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT, Wong YS, Wu CS, Su YH.
    Drug Des Devel Ther; 2017 Oct; 11():1559-1566. PubMed ID: 28572721
    [Abstract] [Full Text] [Related]

  • 7. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.
    Cerebrovasc Dis; 2013 Oct; 35(5):461-8. PubMed ID: 23735898
    [Abstract] [Full Text] [Related]

  • 8. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M, Tütüncü S, Fiebach JB, Scheitz JF, Audebert HJ, Nolte CH.
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology.
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC, Sung SF, Ong CT, Wu CS, Su YH.
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P, Calleja AI, Pérez-Fernández S, Cortijo E, del Monte JM, García-Porrero M, Fe Muñoz M, Fernández-Herranz R, Arenillas JF.
    Cerebrovasc Dis; 2012 Mar; 34(1):31-7. PubMed ID: 22759450
    [Abstract] [Full Text] [Related]

  • 15. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [Abstract] [Full Text] [Related]

  • 16. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Nov; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR, Ahmad A, Shen L, Yeo LL, Loh PK, Ng KW, Chong VF, Ong BK, Venketasubramanian N, Sinha AK, Teoh HL, Bathla G, Chan BP, Sharma VK.
    Cerebrovasc Dis; 2012 Nov; 33(5):446-52. PubMed ID: 22456065
    [Abstract] [Full Text] [Related]

  • 19. Thrombolysis in young adults with ischemic stroke.
    Putaala J, Metso TM, Metso AJ, Mäkelä E, Haapaniemi E, Salonen O, Kaste M, Tatlisumak T.
    Stroke; 2009 Jun; 40(6):2085-91. PubMed ID: 19372446
    [Abstract] [Full Text] [Related]

  • 20. Intravenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator for Acute Ischemic Stroke in Patients with Metabolic Syndrome.
    Sobolewski P, Brola W, Szczuchniak W, Fudala M, Kozera G.
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1787-92. PubMed ID: 25959499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.